bioLytical Launches INSTI® Multiplex HIV-1/2 Syphilis Antibody Test in Australia for Rapid Diagnosis

RICHMOND, British Columbia, bioLytical Laboratories Inc. (“bioLytical”), a global leader in rapid infectious disease diagnostics, announces the...

March 20, 2025 | Thursday | News
SK pharmteco Embarks on My Green Lab Certification to Advance Sustainable Laboratory Practices

-SK pharmteco, a global pharmaceutical subcontract development and manufacturing organization, CDMO), has just reached an important step in its sustainab...

March 14, 2025 | Friday | News
Centivax Partners with Emery Pharma to Advance Potency Testing for Pan-Influenza Vaccine

Centivax, a biotechnology company that develops broad-spectrum vaccines to combat rapidly evolving pathogens, has announced a strategic collaboration with ...

March 12, 2025 | Wednesday | News
Rapid Micro Biosystems Partners with MilliporeSigma for Global Distribution and Collaboration on Growth Direct Systems

Rapid Micro Biosystems, Inc. (the “Company” or “Rapid Micro”), an innovative life sciences technology company providing mission cri...

February 28, 2025 | Friday | News
Avance Biosciences Earns CLIA Registration to Enhance Clinical Trial Support

Avance Biosciences, a leading provider of high-quality analytical and bioanalytical services for the pharmaceutical industry, is pleased to announce that i...

February 27, 2025 | Thursday | News
Alamar Biosciences Launches NULISAqpcr™ Custom Assay Development Kit for Advanced Biomarker Research

Alamar Biosciences, a company that is building the power of high-precision proteomics for early disease detection, is proud to announce the launch of the N...

February 26, 2025 | Wednesday | News
Harvard Bioscience to Showcase Cutting-Edge Innovations at 2025 Society of Toxicology Conference

Harvard Bioscience, Inc. will present its latest product innovations at the Society of Toxicology (SOT) conference, further advancing preclinical research ...

February 25, 2025 | Tuesday | News
Advanced Aesthetic Technologies Receives Approval for Algeness® Dermal Filler in China

Advanced Aesthetic Technologies, Inc. ("AAT") announced  that their partner in China has obtained approval to market their unique dermal fil...

January 29, 2025 | Wednesday | News
Agilent Unveils IDP-35 and IDP-45 Dry Scroll Pumps, Setting New Standards in Quiet, Oil-Free Vacuum Solutions

Agilent Technologies Inc. announced the Agilent IDP-35 and IDP-45 dry scroll pumps, designed to provide quiet, efficient, oil-free, a...

January 21, 2025 | Tuesday | News
QIAcuity Digital PCR Expands Capacity to 12 Targets Simultaneously with New Software Update and High Multiplex PCR Kit

  QIAcuity digital PCR now offers ability for simultaneous detection of up to 12 targets from one biological sample, a more than two-fold inc...

January 13, 2025 | Monday | News
Rise Therapeutics Completes Dose Escalation for R-2487 and R-3750, Advancing to Dose Expansion in Clinical Trials

Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines,  announced that it has completed dose esc...

January 07, 2025 | Tuesday | News
Adcentrx Doses First Patient in Phase 1a/b Study of ADRX-0405 for Advanced Solid Tumors

 Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company advancing innovative protein conjugates for cancer and other life-thr...

January 07, 2025 | Tuesday | News
ADC Therapeutics Completes Enrollment in Phase 3 LOTIS-5 Trial of ZYNLONTA® (Loncastuximab Tesirine) for Relapsed or Refractory DLBCL

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs),  announced the co...

December 31, 2024 | Tuesday | News
FDA Approves Zepbound® (Tirzepatide) as First Treatment for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity

Eli Lilly and Company (NYSE: LLY) announced the U.S. Food and Drug Administration (FDA) approved Zepbound® (tirzepatide) as the fir...

December 21, 2024 | Saturday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close